Modification of in Vitro Cytotoxicity of Lymphocytes from Patients with Chronic Ulcerative Colitis or Granulomatous Colitis for Allogenic Colonic Epithelial Cells-Reference-Cited by-同舟云学术

Modification of in Vitro Cytotoxicity of Lymphocytes from Patients with Chronic Ulcerative Colitis or Granulomatous Colitis for Allogenic Colonic Epithelial Cells

Published:1970-05 Issue:5 Volume:58 Page:692-698
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Shorter Roy G.,Cardoza Martha R.,Remine Stephen G.,Spencer Robert J.,Huizenga Kenneth A.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference22 articles.

1. Present status of immunological mechanisms in ulcerative colitis;Kraft;Gastroenterology,1966

2. Immune responses and the gut;Watson;Gastroenterology,1969

3. In vitro studies of ulcerative colitis. II. Cytotoxic action of white blood cells from patients on hu man fetal colon cells;Perlmann;J. Exp. Med,1963

4. Effect of lymphocytes from patients with ulcerative colitis on human adult colon epithelial cells;Watson;Gastroenterology,1966

5. Further studies of in vitro cytotoxicity of lymphocytes from pa tients with ulcerative and granulomatous colitis for allogenic colonic epithelial cells, including the effects of colectomy;Shorter;Gastroenterology,1969

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review: gut sterilization in inflammatory bowel disease;Alimentary Pharmacology & Therapeutics;2007-03-31

2. Immunosuppressants and operation in ulcerative colitis1 1No competing interests declared.Invited lecture at the American College of Surgeons 86th Annual Clinical Congress, Chicago, IL, October 2000.;Journal of the American College of Surgeons;2002-08

3. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial;The Lancet;1999-08

4. The aetiology of Crohn's disease;International Journal of Colorectal Disease;1986-09

5. Inhibition of cytotoxicity by sulfasalazine. I. Sulfasalazine inhibits spontaneous cell-mediated cytotoxicity by peripheral blood and intestinal mononuclear cells from control and inflammatory bowel disease patients;Immunopharmacology;1986-04